Neuren Pharmaceuticals (ASX:NEU) – Webinar Presentation

Jon Pilcher – Managing Director & CEO – Neuren Pharmaceuticals Limited (ASX:NEU) is developing new therapies for highly debilitating neurodevelopmental disorders that emerge in early childhood.